Ahmet Topuzoğlu1, Tolga Binbay2, Halis Ulaş3, Hayriye Elbi4, Feride Aksu Tanık5, Nesli Zağlı6, Köksal Alptekin2. 1. Dokuz Eylul University, Department of Psychiatry, Izmir, Turkey. Electronic address: drtopuzoglu@gmail.com. 2. Dokuz Eylul University, Department of Psychiatry, Izmir, Turkey. 3. Dokuz Eylul University, School of Medicine, Department of Psychiatry, Izmir, Turkey. 4. Ege University, School of Medicine, Department of Psychiatry, Izmir, Turkey. 5. Ege University, School of Medicine, Department of Public Health, Izmir, Turkey. 6. Ege University, Department of Psychiatry, Izmir, Turkey.
Abstract
BACKGROUND: Subclinical and clinical depression is common, widely distributed in the general population, and usually associated with role impairment and help-seeking. Reliable information at the population level is needed to estimate the disease burden of depression and associated care needs in Turkey. METHOD: The cross-sectional study aimed to assess the prevalence of subthreshold (SubD) and clinical major depressive disorder (MDD) in Izmir, Turkey. In the 5242 eligible households, a total of 4011 individuals were successfully interviewed, yielding a response rate of 76.5%. Prevalence estimates of MDD and SubD depression were formed by using the responses to the questions of the CIDI section E. Short Form 36 (SF-36) to assess health status and functional impairments in eight scaled scores during the last four weeks. All respondents were questioned about receiving 12-month treatment for any psychological complaints, the route of help-seeking, as well as prescribed medicines and any hospitalization. RESULTS: The one year prevalence estimate for CIDI/DSM IV MDD was 8.2% (95% CI, 7.4-9.1). Less educated, low income, uninsured, low SES, unemployed/disabled and housewives, slum area residents had higher one year MDD prevalence. Determined prevalence of help seeking from mental health services of SubD and MDD cases were 23.6%, 30.6% respectively. Only 24.8% of clinically depressive patients received minimally adequate treatment. LIMITATIONS: Cross sectional design. CONCLUSION: Higher MDD prevalence correlates with younger ages, female gender, unemployment, less education, lower monthly income, lower SES and uninsurance. Help seeking from mental health services were low. There are treatment gap and impairment in depressive group.
BACKGROUND: Subclinical and clinical depression is common, widely distributed in the general population, and usually associated with role impairment and help-seeking. Reliable information at the population level is needed to estimate the disease burden of depression and associated care needs in Turkey. METHOD: The cross-sectional study aimed to assess the prevalence of subthreshold (SubD) and clinical major depressive disorder (MDD) in Izmir, Turkey. In the 5242 eligible households, a total of 4011 individuals were successfully interviewed, yielding a response rate of 76.5%. Prevalence estimates of MDD and SubD depression were formed by using the responses to the questions of the CIDI section E. Short Form 36 (SF-36) to assess health status and functional impairments in eight scaled scores during the last four weeks. All respondents were questioned about receiving 12-month treatment for any psychological complaints, the route of help-seeking, as well as prescribed medicines and any hospitalization. RESULTS: The one year prevalence estimate for CIDI/DSM IV MDD was 8.2% (95% CI, 7.4-9.1). Less educated, low income, uninsured, low SES, unemployed/disabled and housewives, slum area residents had higher one year MDD prevalence. Determined prevalence of help seeking from mental health services of SubD and MDD cases were 23.6%, 30.6% respectively. Only 24.8% of clinically depressivepatients received minimally adequate treatment. LIMITATIONS: Cross sectional design. CONCLUSION: Higher MDD prevalence correlates with younger ages, female gender, unemployment, less education, lower monthly income, lower SES and uninsurance. Help seeking from mental health services were low. There are treatment gap and impairment in depressive group.
Authors: Yuwei Deng; Jacob Cherian; Noor Un Nisa Khan; Kalpina Kumari; Muhammad Safdar Sial; Ubaldo Comite; Beata Gavurova; József Popp Journal: Front Psychiatry Date: 2022-06-16 Impact factor: 5.435
Authors: Sherry L Grace; Yongyao Tan; Robert A Cribbie; Han Nguyen; Paul Ritvo; Jane Irvine Journal: BMC Psychiatry Date: 2016-02-26 Impact factor: 3.630